Last $6.50 USD
Change Today +0.67 / 11.49%
Volume 438.1K
TROV On Other Exchanges
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Antonius P. Schuh Ph.D.

Chief Executive Officer and Director, TrovaGene, Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Antonius P. Schuh, Ph.D., has been the Chief Executive Officer of TrovaGene, Inc., since October 2011. Dr. Schuh serves as the Chief Executive Officer of Quikbyte Software, Inc. He served as the Chairman and Chief Executive Officer of Sorrento Therapeutics, Inc. from September 2009 to April 1, 2011 and served as its President until April 1, 2011. He co-founded Sorrento Therapeutics, Inc. He served as the Chief Executive Officer of BioTheranostics, Inc. since March ...

Read Full Background

Corporate Headquarters*

11055 Flintkote Avenue
San Diego, California 92121

United States

Phone: 858-952-7570
Fax: --

Board Members Memberships*

Former Chief Executive Officer and Director
Independent Director
Former Chief Executive Officer, President and Director
Former Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Former Chairman, Chief Executive Officer and President
Chief Executive Officer and Director


Rheinische Friedrich-Wilhelms-Universität Bonn
Bachelor's Degree
Rheinische Friedrich-Wilhelms-Universität Bonn

Other Affiliations*

Annual Compensation*

Total Annual Compensation$533,125

Stock Options*

Exercisable Options316,666
Unexercisable Options566,667
Total Number of Options883,333

Total Compensation*

Total Annual Cash Compensation$533,125
Total Short Term Compensation$533,125
Total Calculated Compensation$1,746,089
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TROV:US $6.50 USD +0.67


Gajus V. Worthington Co-Founder, Chief Executive Officer, President and Director
Fluidigm Corporation
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TROVAGENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at